These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 19998193)
1. The rationale for placebo-controlled trials: methodology and policy considerations. Miller FG Am J Bioeth; 2009 Sep; 9(9):49-50. PubMed ID: 19998193 [No Abstract] [Full Text] [Related]
2. Strengthening Howick's argument against the alleged superiority of placebo-controlled trials. Rennie S; Stürmer T Am J Bioeth; 2009 Sep; 9(9):62-4. PubMed ID: 19998200 [No Abstract] [Full Text] [Related]
3. Control theory: placebo-controlled drug trials have problems. Active-controlled drug trials are not always the solution. Golomb BA Am J Bioeth; 2009 Sep; 9(9):67-9. PubMed ID: 19998203 [No Abstract] [Full Text] [Related]
4. Conflating scientific with clinical considerations. van der Graaf R; van Delden JJ Am J Bioeth; 2009 Sep; 9(9):58-9. PubMed ID: 19998198 [No Abstract] [Full Text] [Related]
5. Research, medicine, and "placebos". Moerman DE Am J Bioeth; 2009 Sep; 9(9):64-5. PubMed ID: 19998201 [No Abstract] [Full Text] [Related]
6. Placebo misconceptions. Senn S Am J Bioeth; 2009 Sep; 9(9):53-4. PubMed ID: 19998195 [No Abstract] [Full Text] [Related]
7. When do the federal regulations allow placebo-controlled trials in children? Miller FG; Wendler D; Wilfond B J Pediatr; 2003 Feb; 142(2):102-7. PubMed ID: 12584527 [No Abstract] [Full Text] [Related]
8. Preparing for a post-placebo paradigm: ethics and choice of control in clinical trials. Nunn R Am J Bioeth; 2009 Sep; 9(9):51-2. PubMed ID: 19998194 [No Abstract] [Full Text] [Related]
9. Questioning the methodologic superiority of 'placebo' over 'active' controlled trials. Howick J Am J Bioeth; 2009 Sep; 9(9):34-48. PubMed ID: 19998192 [TBL] [Abstract][Full Text] [Related]
10. A clinical perspective on placebo research: looking back, looking forward. Dworkin RW Am J Bioeth; 2009 Sep; 9(9):54-5. PubMed ID: 19998196 [No Abstract] [Full Text] [Related]
11. Who's in control of the choice of control? Anderson JA Am J Bioeth; 2009 Sep; 9(9):60-2. PubMed ID: 19998199 [No Abstract] [Full Text] [Related]
12. Ethical issues in the difference between placebo-controlled and active-controlled trials. Petrini C Am J Bioeth; 2009 Sep; 9(9):56-8. PubMed ID: 19998197 [No Abstract] [Full Text] [Related]
14. Questioning the methodological superiority of 'placebo' over 'active' controlled trials. Enkin MW Am J Bioeth; 2009 Sep; 9(9):66-7. PubMed ID: 19998202 [No Abstract] [Full Text] [Related]
15. Exploitation and the ethics of clinical trials. Resnik DB Am J Bioeth; 2002; 2(2):28-30. PubMed ID: 12189070 [No Abstract] [Full Text] [Related]
16. Can we eliminate placebo in ALS clinical Trials? Simmons Z Muscle Nerve; 2009 Jun; 39(6):861-5. PubMed ID: 19382170 [TBL] [Abstract][Full Text] [Related]
17. Historical control monotherapy design in the treatment of epilepsy. French JA; Wang S; Warnock B; Temkin N Epilepsia; 2010 Oct; 51(10):1936-43. PubMed ID: 20561024 [TBL] [Abstract][Full Text] [Related]
19. Reviewing the unsubstantiated claims for the methodological superiority of 'placebo' over 'active' controlled trials: reply to open peer commentaries. Howick J Am J Bioeth; 2009 Sep; 9(9):W5-7. PubMed ID: 19998178 [No Abstract] [Full Text] [Related]
20. In brief: Non-inferiority trials. Med Lett Drugs Ther; 2011 Jan; 53(1355):1. PubMed ID: 21212743 [No Abstract] [Full Text] [Related] [Next] [New Search]